Cornerstone Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.61M Buy
3,875
+14
+0.4% +$16.5K 0.95% 34
2026
Q2
$4.63M Buy
3,861
+370
+11% +$378K 1.07% 30
2026
Q1
$3.21M Sell
3,491
-462
-12% -$468K 0.73% 49
2025
Q4
$4.23M Buy
+3,953
New +$3.78M 0.98% 34
2024
Q4
$2.03M Buy
+2,632
New +$2.18M 0.78% 37

Other funds holding LLY

Cornerstone Planning's LLY Position: Q3 2026 in Review

Cornerstone Planning increased its Eli Lilly (LLY) stake by 0.36% in Q3 2026, buying an estimated $16.5K and bringing the position to 3,875 shares worth $4.61M. The position accounts for 0.95% of the portfolio, ranked #34.

Cornerstone Planning first reported a position in LLY in Q4 2024 and has held it in 5 quarters since. The position peaked at $4.63M in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Cornerstone Planning held 3,875 shares of Eli Lilly worth $4.61M as of Q3 2026.
  • Cornerstone Planning bought 14 Eli Lilly shares in Q3 2026, an estimated $16.5K.
  • Eli Lilly made up 0.95% of Cornerstone Planning's portfolio in Q3 2026, its #34 holding.
  • Cornerstone Planning first reported a position in Eli Lilly in Q4 2024 and has held it in 5 quarters since.
  • Cornerstone Planning's Eli Lilly position peaked at $4.63M in Q2 2026.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cornerstone Planning's 13F filing for Q3 2026, filed 27 Oct 2026.